Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Dacogen decitabine: Preliminary Phase II data

Preliminary data from 99 patients in an open-label Phase II trial showed that 20

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE